Schwarz, Dan http://orcid.org/0000-0002-6975-4519
Dhungana, Santosh
Kumar, Anirudh
Acharya, Bibhav
Agrawal, Pawan
Aryal, Anu
Baum, Aaron
Choudhury, Nandini
Citrin, David
Dangal, Binod
Dhimal, Meghnath
Gauchan, Bikash
Gupta, Tula
Halliday, Scott
Karmacharya, Biraj
Kishore, Sandeep
Koirala, Bhagawan
Kshatriya, Uday
Levine, Erica
Maru, Sheela
Rimal, Pragya
Sapkota, Sabitri
Schwarz, Ryan
Shrestha, Archana
Thapa, Aradhana
Maru, Duncan
Article History
Received: 28 September 2019
Accepted: 9 January 2020
First Online: 29 January 2020
Ethics approval and consent to participate
: This study has been approved by the Ethical Review Board of the Nepal Health Research Council (#177/2018). Within the study, all patients will provide verbal informed consent to have their de-identified data analyzed and published. Care provision will be unrelated to consent, and there will be no difference in care provision based on consent status. Verbal informed consent will also be provided by all KII and FGD participants. No incentives will be provided to study participants, to avoid any conflict of interest or coercion to participate.
: Not applicable.
: PA, AA, DC, BD, BG, TG, UK, PR, SS, and AT are employed by, and DS, BA, NC, SH, SM, RS, and DM work in partnership with, a nonprofit healthcare company (Nyaya Health Nepal, with support from the US-based nonprofit organization, Possible) that delivers free healthcare in rural Nepal using funds from the Government of Nepal and other public, philanthropic, and private foundation sources. DS and RS are employed at an academic medical center (Brigham and Women’s Hospital) that receives public-sector research funding, as well as revenue through private-sector fee-for-service medical transactions and private foundation grants. DS and RS are faculty members at a private medical school (Harvard Medical School). DS is employed at an academic medical center (Beth Israel Deaconess Medical Center) that receives public-sector research funding, as well as revenue through private-sector fee-for-service medical transactions and private foundation grants. DS is employed at an academic research center (Ariadne Labs) that is jointly supported by an academic medical center (Brigham and Women’s Hospital) and a private university (Harvard T.H. Chan School of Public Health) via public-sector research funding and private philanthropy. SD is a medical resident at a private academic medical center (Hurley Medical Center) that receives revenue through private-sector fee-for-service medical transactions and a charitable private foundation. AK is a medical resident at a private academic medical center (NYU Langone Health) that receives public-sector research funding, as well as revenue through private-sector fee-for-service medical transactions and private foundation grants. BA is a faculty member at a public university (University of California, San Francisco). AA is a fellow supported by a public-sector research fellowship affiliated at, and BKa and AS are faculty members at, a private university (Kathmandu University). DC is a faculty member at, SH is a graduate student at, and DC and SH are employed part-time at a public university (University of Washington). AB, DC, SK, SM, SS, and DM are faculty members at, and NC, SH, and EL are employed by, a private medical school (Icahn School of Medicine at Mount Sinai). MD is employed by the Government of Nepal (Ministry of Health and Population, Nepal Health Research Council). TG is a fellow with a bidirectional fellowship program (HEAL Initiative) that is affiliated with a public university (University of California, San Francisco) that receives funding from public, philanthropic, and private foundation sources. BKa is a faculty member at a public research university (Sun Yat-sen University). SK is the founding Executive Director at an advocacy and leadership network (Young Professionals Chronic Disease Network) that receives funding from individual philanthropy. SK serves as a consultant for Resolve To Save Lives on hypertension treatment and leads a partnership on multiple chronic conditions through his institution and Teva Pharmaceuticals. BKo is a faculty member at a public university (Tribhuvan University, Institute of Medicine). SM is a voting member on the Board of Directors with Group Care Global, a position for which she receives no compensation. RS is employed at an academic medical center (Massachusetts General Hospital) that receives public-sector research funding, as well as revenue through private-sector fee-for-service medical transactions and private foundation grants. AS is a faculty member at a private university (Yale School of Public Health). DM is a nonvoting member on Possible’s Board of Directors, a position for which he receives no compensation. All authors have read and understood <i>Trials</i>’ policy on declaration of interests, and declare that they have no competing financial interests. The authors do, however, believe strongly that healthcare is a public good, not a private commodity.